(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…
Source link : https://www.medpagetoday.com/obgyn/menopause/119031
Author :
Publish date : 2025-12-15 22:41:00
Copyright for syndicated content belongs to the linked Source.
